Skip to main content
. 2022 May 3;100(2):562–588. doi: 10.1111/1468-0009.12565

Figure 3.

Figure 3

Coverage With Utilization Restrictions for Protected and Nonprotected Drugs According to Drug‐Related Characteristics

Abbreviations: CMS, Centers for Medicare and Medicaid Services; FDA, US Food and Drug Administration

Results obtained from enrollment‐weighted multivariable logistic regression analysis, also controlling for approval year and plan type. Bars represent the subset of plans that cover new drugs. For example, over 90% of plans that covered drugs in CMS protected classes had utilization management tools. None of the differences was statistically significant.